Sunday, June 22, 2025
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home 2020 September

Monthly Archives: September 2020

aPHEX bIOcLEANSE
Superbug News - CoronaVirus Watch List

Hy-IQ Trademark

Editor / Curator -
Biotech News

Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.

Editor / Curator -
2020 Watch List

Immunomedics (IMMU) $3.00 to $88, Up 29-fold, Our Second Best Idea...

Editor / Curator -
American BriVision
Biotech News

American BriVision’s (ABVC) Clinical Study Sparks Interest From Potential Partners.

Editor / Curator -
Internet Stock Review
Internet News

Peleton (PTON) Hits $25 Billion Valuation. Calm (Private) Hits Unicorn Valuation...

Editor / Curator -
Biotech News

Corbus Pharma (CRBP) Body Slammed -75%.

Editor / Curator -
Stand Down.

Dow 36,000 – S&P 500 4,500 – NASDAQ 15,000. Then a...

Editor / Curator -
biotech stock review
Superbug News - CoronaVirus Watch List

Adding Fluidigm (FLDM) $6.14, to Corona Stock Watch List.

Editor / Curator -
Inovie, Biotech Stock Review
Infections

Shorts Set $1.00 Price Target on Inovio (INO) $9.20.

Editor / Curator -
Drones

Autel Drones Made in U.S.: What “Made in America” Means for...

Editor / Curator -
123Page 2 of 3

Latest article

Jeffrey Gundlach: Reckoning is Coming.

All News Editor / Curator -
Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm. On 11 November 2020, Gundlach remarked in an interview with...

Who’s the Next Eric Sprott?

All News Editor / Curator -
Eric Sprott, on Who is the Next Eric Sprott! To say Eric Sprott has left a legendary mark on the world of mining investment would...

Perpetua (PPTA) Raises $300 Million.

All News Editor / Curator -
Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.